Question Checklist –Test Questions

Being prepared for office visits assists your doctor in determining your medical needs and most appropriate treatment plan; helps you receive timely access to medical care and related services, and created a mutually respectful and supportive relationship. Besides bringing along a companion, one if the best ways to prepare for a visit is prepare a concise list of written questions. Provide a copy for your doctor.

  • o What tests will you order?
  • o What will the tests show or indicate?
  • o Will you provide copies of the results?
  • o How often should I receive these tests?
  • o What toxicity and/or risks are associated with this test – or the repeated long-term use of this test? Is there a safer alternative?
  • o What changes or symptoms may indicate the need for tests?
  • o What test results indicate a need to initiate or change treatment?
  • o When is a bone marrow biopsy indicated?
  • o What steps will you take to minimize the discomfort and anxiety associated with the
    bone marrow test?
Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap